Oliver Kepp - INSERM, Scientific Co-Founder at Samsara Therapeutics | The Org
Oliver KEPP | Ph.D. | Institut de Cancérologie Gustave Roussy, Villejuif | IGR | Research profile
Five Highly Cited Researchers in 2021 at the Centre de Recherche des Cordeliers - Centre de recherche des Cordeliers
Oliver Kepp: H-index & Awards - Academic Profile | Research.com
Intratumor heterogeneity and cell secretome promote chemotherapy resistance and progression of colorectal cancer | Cell Death & Disease
Oliver KEPP | Ph.D. | Institut de Cancérologie Gustave Roussy, Villejuif | IGR | Research profile
Bak and Bax are non‐redundant during infection‐ and DNA damage‐induced apoptosis | The EMBO Journal
Prof. Oliver Kepp - Samsara Therapeutics
Loop | Oliver Kepp
Oliver Kepp – Werkstudent – DATEV eG | LinkedIn
Academi-Text B2B: International Review of Cell and Molecular Biology: Biology of the Endoplasmic Recticulum : 0128197447 : Kepp, Oliver : Medical Books : Medicine : Biochemistry
Monitoring Vesicular Trafficking in Cellular Responses to Stress, Volume 164 - 1st Edition
Quantification of cellular viability by automated microscopy and flow cytometry
Cell Senescence: Methods and Protocols | SpringerLink
Prerequisites for the Antitumor Vaccine-Like Effect of Chemotherapy and Radiotherapy
Hallmarks of cancer - Detect and quantify cell death signatures with high content imaging - YouTube
Oliver Kepp – Werkstudent – DATEV eG | LinkedIn
Loop | Oliver Kepp
Crizotinib-induced immunogenic cell death in non-small cell lung cancer | Nature Communications
Customer Breakthroughs - Gustave Roussy Cancer Center | Molecular Devices
Oliver Kepp - INSERM, Scientific Co-Founder at Samsara Therapeutics | The Org
Customer Breakthroughs - Gustave Roussy Cancer Center | Molecular Devices
Highly Cited Researchers 2022: 6 CARPEM researchers among the most cited in the world - Carpem.fr